跳至主要内容
临床试验/NCT04718727
NCT04718727已完成1 期

Olanzapine for the Prevention of Postoperative Nausea and Vomiting After Laparoscopic Surgery in High-risk Patients: A Randomized Controlled Trial

Amani Hassan Abdel-Wahab2 个研究点 分布在 1 个国家目标入组 132 人开始时间: 2021年3月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
132
试验地点
2
主要终点
nausea and/or vomiting score

研究概览

简要总结

Nausea and vomiting (PONV) remain a common problem in surgical units. Even after two or three prophylactic antiemetic interventions, patients with all four of the Apfel risk factors for PONV have an estimated 30 to 40% chance of suffering PONV. Olanzapine as an antiemetic represents a new use of an antipsychotic drug.

详细描述

Aim of the Research, to compare the effects of oral 10 and 5 mg Olanzapine for the Prevention of Postoperative Nausea and Vomiting

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • ASA I and II patients
  • undergoing ambulatory laparoscopic gynecologic surgery with general anesthesia
  • patients have at least two of the four Apfel risk factors for PONV2
  • Lack of history of psychiatric and psychotic illnesses.

排除标准

  • ASA III and ≥ IV patients
  • Psychological diseases
  • History of chemotherapy
  • have a pre-existing vestibular disorder or history of dizziness or preexisting nausea or vomiting in the 24 h before surgery, or were being treated with regular antiemetic therapy including systemic corticosteroids.

研究组 & 干预措施

Group 1

Placebo Comparator

patients will receive oral placebo tablets one hour preoperatively

干预措施: Placebo (Drug)

Group 2

Active Comparator

patients will receive oral 5 mg Olanzapine tablets one hour preoperatively

干预措施: 5 mg Olanzapine Tablets (Drug)

Group 3

Active Comparator

patients will receive oral 10 mg Olanzapine tablets one hour preoperatively

干预措施: 10 mg Olanzapine Tablets (Drug)

结局指标

主要结局

nausea and/or vomiting score

时间窗: first 24 hours postoperative

the occurrence of nausea and/or vomiting by nausea score

次要结局

未报告次要终点

研究者

发起方
Amani Hassan Abdel-Wahab
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Amani Hassan Abdel-Wahab

assistant professor

Assiut University

研究点 (2)

Loading locations...

相似试验